General Information of the Compound
| Compound ID |
CP0048177
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2R,3R)-2,3-dihydroxysuccinic acid;1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol
Show/Hide
|
||||||||||||||||||
| Synonyms |
(RS)-Metoprolol
1-(Isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol
1-(Isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol
1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol
1-[(1-methylethyl)amino]-3-({4-[2-(methyloxy)ethyl]phenyl}oxy)propan-2-ol
1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol
1-[4-(2-methoxyethyl)phenoxy]-3-propan-2-ylamino-propan-2-ol
3-[4-(2-methoxyethyl)phenoxy]-1-(propan-2-ylamino)propan-2-ol
AstraZeneca Brand of Metaoprolol Tartrate
AstraZeneca Brand of Seloken
Beatrolol
Beloc Duriles
Beloc-Duriles
BelocDuriles
Betaloc
Betaloc (TN)
Betaloc Astra
Betaloc-Astra
BetalocAstra
Betalok
CGP 2175
CGP-2175
CGP2175
Corvitol (TN)
Dl-Metoprolol
Dutoprol
H 93 26
H 93-26
H 9326
LOPRESSIDONE
Leiras Brand of Metoprolol Succinate or Metoprolol Tartrate
Lopresor
Lopresoretic
Lopressor
Lopressor (TN)
Meijoprolol
Metohexal
Metoprolol
Metoprolol (USAN/INN)
Metoprolol [USAN:INN:BAN]
Metoprolol succinate
Metoprololum
Metoprololum [INN-Latin]
Metrol (TN)
Metroprolol
Minax (TN)
Neobloc (TN)
Novartis Brand of Metprolol Tartrate
Preblok
Presolol
Selo-Zok
Selokeen (TN)
Seloken
Seloken AstraZeneca Brand
Seroken
Spesicor
Spesikor
TOPROL-XL
Tartrate, Metoprolol
Toprol
Toprol-XL (TN)
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C15H25NO3
|
||||||||||||||||||
| Molecular Weight |
267.369
|
||||||||||||||||||
| Canonical SMILES |
COCCc1ccc(OCC(O)CNC(C)C)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C15H25NO3/c1-12(2)16-10-14(17)11-19-15-6-4-13(5-7-15)8-9-18-3/h4-7,12,14,16-17H,8-11H2,1-3H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
IUBSYMUCCVWXPE-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
37350-58-6
54163-88-1
51384-51-1
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06365, Beta-1 adrenergic receptor
Protein ID: PT01179, Beta-1 adrenergic receptor
Protein ID: PT02505, Beta-1 adrenergic receptor
Protein ID: PT01494, Beta-2 adrenergic receptor
Clinical Information about the Compound